<DOC>
	<DOCNO>NCT03044301</DOCNO>
	<brief_summary>The aim study evaluate performance ZENEO needle free device subcutaneous function limit ( low performance limit high performance limit ) intramuscular injection .</brief_summary>
	<brief_title>Performance Thresholds Evaluation Wet Injection Quantification Magnetic Resonance Imaging ( MRI ) Subcutaneous Intramuscular Injections ( 0,65ml ) Several Configurations Needle-free Devices ( ZENEO® )</brief_title>
	<detailed_description />
	<criteria>male female healthy volunteer age 18 60 year , affiliate covered French social security system , BMI ≥20 ≤30 kg/m² Patients without chronic medical surgical illness Patients normal clinical examination screen visit , Patients normal blood pressure screen visit : systolic BP &lt; 140 mmHg diastolic BP &lt; 90 mmHg , determine patient seat rest least 5 minute , Patients within normal range value follow laboratory test ( appendix I ) unless investigator considers abnormality clinically irrelevant ( document agree sponsor inclusion ) within 1 month prior start study ( MRI sub study volunteer ) , Absence cannabis , opiate , cocaine , amphetamine history ( MRI sub study volunteer ) history drug abuse history hypersensitivity ( disease drug ) treatment platelet inhibit drug within one week inclusion treatment anticoagulant within four week inclusion subject likely take medication study contraindication MRI : metallic intracorporeal device , claustrophobia prior participation interventional clinical research within 3 month custody due administrative legal decision tutelage admit sanitary social institution .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>